|
11. |
Role of p53 and p21/WAF1 detection in patient selection for preoperative radiotherapy in rectal cancer patients |
|
Diseases of the Colon & Rectum,
Volume 41,
Issue 1,
1998,
Page 68-74
Chuan‐Gang Fu,
Osamu Tominaga,
Hirokazu Nagawa,
Marcelo Eidi Nita,
Tadahiko Masaki,
Gosei Ishimaru,
Yoshiki Higuchi,
Takashi Tsuruo,
Tetsuichiro Muto,
Preview
|
PDF (4208KB)
|
|
摘要:
BACKGROUND:Recent studies showed that p53 and p21 may play major roles in determining tumor radiosensitivity through the apoptosis pathway. The aim of this study was to investigate the predicting value of radiosensitivity in human rectal carcinoma.METHODS:p53 and p21/WAF1 expressions in formalin fixed, paraffin‐embedded, preradiation biopsy samples from 49 patients with primary rectal carcinoma were analyzed immunohistochemically. p53 and p21 expressions and their relationships with histopathologic changes after radiation and other clinical features were evaluated.RESULTS:Expressions of p53 and p21/WAF1 were 49 and 28.6 percent, respectively. In 36.7 percent of total tumors, significant histopathologic effect can be observed. There was a significant inverse expression of p53 and p21. Most of the p53(+) or p21(−) tumors were radioresistant, and the majority of p53(−) or p21(+) tumors were radiosensitive. Tumors size in the radiosensitive, p53(−), or p21(+) group decreased more significantly than in radioresistant, p53(+), or p21(−) group (P<0.01), and patients with radioresistant, p53(+), or p21(−) tumors had more local recurrence, more distant metastasis, and a shorter five‐year survival rate than those with radiosensitive, p53(−), or p21(+) tumors, but without statistic significance. No statistically significant correlation can be observed between other tumor clinical features and radiosensitivity, p53, or p21 expressions.CONCLUSION:Immunohistochemistry detection of p53 and p21 expressions may be useful parameters for more radiosensitive patients selected for preoperative radiotherapy.
ISSN:0012-3706
出版商:OVID
年代:1998
数据来源: OVID
|
12. |
Appendiceal tumorsRetrospective clinicopathologic analysis of appendiceal tumors from 7,970 appendectomies |
|
Diseases of the Colon & Rectum,
Volume 41,
Issue 1,
1998,
Page 75-80
S. Connor,
G. Hanna,
F. Frizelle,
Preview
|
PDF (646KB)
|
|
摘要:
BACKGROUND:Appendiceal tumors are rare and often unexpectedly discovered in an acute situation, in which decision‐making is difficult. To help define the most appropriate management, a retrospective analysis was undertaken to describe the clinicopathologic behavior of appendiceal tumors, and the literature was reviewed of the management of the different types of appendiceal tumors.METHOD:From a single center, a histopathologic database of 7,970 appendectomies, all appendiceal tumors, were identified and case notes reviewed. Analysis of clinical presentation, histopathology, operation, and outcome is presented.RESULTS:During a 16‐year period (7,970 appendectomies), 74 patients (0.9 percent) with appendiceal tumors were identified: 42 carcinoid, 12 benign, and 20 malignant. Acute appendicitis was the most common presentation (49 percent), and 9.5 percent were incidental findings. Primary malignant tumors of the appendix were found in 0.1 percent of all appendectomies. Secondary malignant disease was identified in the appendix of 11 patients, most commonly (55 percent) from patients with primary colorectal disease. There was a high incidence of synchronous and metachronous colorectal cancer in all appendiceal tumors: carcinoids, 10 percent; benign tumors, 33 percent; secondary malignancies, 55 percent; primary malignancies, 89 percent.CONCLUSION:Appendiceal tumors are uncommon and most often present as appendicitis. Most are benign and can be managed by appendectomy, except adenocarcinomas and carcinoids larger than 2 cm, which are most appropriately managed by right hemicolectomy. A suggested management algorithm is provided. Controversy exists over the management of carcinoids 1 to 2 cm in size and adenocarcinoids. All types of appendiceal tumors have a high incidence of synchronous and metachronous colorectal cancer.
ISSN:0012-3706
出版商:OVID
年代:1998
数据来源: OVID
|
13. |
Perianal infections in patients with leukemiaImportance of the course of neutrophil count |
|
Diseases of the Colon & Rectum,
Volume 41,
Issue 1,
1998,
Page 81-85
Yahya Büyükaşık,
Osman Özcebe,
Nilgün Sayınalp,
Ibrahim Haznedaroğlu,
Özden Altundağ,
Oktay Özdemir,
Semra Dündar,
Preview
|
PDF (635KB)
|
|
摘要:
PURPOSE:This study was performed to evaluate relations among neutrophil count (including its course), type of lesion, treatment, and prognosis in patients with leukemia and perianal infection.METHODS:Medical records of patients with acute and chronic leukemia who were followed during the last five years were reviewed retrospectively.RESULTS:The incidence of perianal infections was found to be 7.3 percent in 259 patients with acute leukemia. Only 1 of 108 patients with chronic leukemia suffered from this problem. Twenty percent of all patients with this complication died as a result of sepsis. Perianal abscess was the sole and obligatory indication for surgical treatment in our patients. There were ten patients in each treatment group. The operative group had better results (9 cures, 1 complicationvs.3 cures, 7 complications). However, median neutrophil count at diagnosis was notably higher in the operative group 1,280/mm3vs.96/mm3;P=0.075). Also, significantly more frequent abscess formations and, consequently, operative treatments were performed in patients with a period of normal neutrophil counts during the infection compared with continuously neutropenic patients (9 operative, 4 nonoperativevs.1 operative, 6 nonoperative;P=0.057). Ten cures, three complicationsvs.two cures, five complications (3 mortalities) were present in patients with and without normal neutrophil counts, respectively (P=0.062). When only severely neutropenic patients were considered, four patients in the surgery group had normal neutrophil counts before or shortly after surgery. However, only two of eight patients with perianal cellulitis had normal counts during full‐course infection (P=0.06).CONCLUSIONS:The course of the neutrophil count during infection was an important factor affecting the perianal lesion, and indirectly, choice of treatment and prognosis. A period of normal counts during infection usually led to well bordered and fluctuant lesions, and the prognosis was acceptable with operative treatment. However, continuously neutropenic patients developed nonfluctuating indurations. We found disappointing results with nonoperative treatment of such patients. In all studies, regarding treatment of perianal infections in neutropenic patients, the course of the neutrophil count and indications for surgery should be clarified to get reliable results.
ISSN:0012-3706
出版商:OVID
年代:1998
数据来源: OVID
|
14. |
Mucosal tenascin C content in inflammatory and neoplastic diseases of the large bowel |
|
Diseases of the Colon & Rectum,
Volume 41,
Issue 1,
1998,
Page 86-92
Stefan Riedl,
Martina Kadmon,
Andrea Tandara,
Ulf Hinz,
Peter Möller,
Christian Herfarth,
Andreas Faissner,
Preview
|
PDF (820KB)
|
|
摘要:
PURPOSE:Tenascin C is a glycoprotein of the extracellular matrix. It is upregulated during embryologic development, wound healing, and under conditions of normal and neoplastic growth. Most available data on tenascin C expression in tissues is based on immunohistologic studies. The present study was designed to quantify tissue concentrations in patients with inflammatory and neoplastic diseases of the large bowel.METHODS:Fifty patients with ulcerative colitis, 19 patients suffering from familiar adenomatous polyposis without malignant transformation, and 69 patients with colorectal carcinoma were investigated. Tenascin C concentrations in tissue extracts were determined by semiquantitative Western blotting.RESULTS:The tenascin C tissue concentration of normal mucosa was 2.6±3.4 &mgr;g/mg (n=55), 2.9±2.1 &mgr;g/mg in colorectal adenomas (n=19), 7.5±4.7 &mgr;g/mg in ulcerative colitis (n=50), and 18±15 &mgr;g/mg in colorectal carcinomas (n=69; mean ± standard deviation). In ulcerative colitis, the mucosal tenascin C content correlated with histopathologic disease activity. No differences were found between subgroups of adenomas or carcinomas.CONCLUSIONS:Tenascin C tissue concentrations were not altered in adenomas, slightly elevated in ulcerative colitis, and substantially increased in colorectal carcinomas. Although less useful as a diagnostic parameter, tenascin C tissue levels serve as an instrument for assessing the activity of stromal remodeling in largebowel diseases generally. Specifically, they may reflect disease activity in ulcerative colitis.
ISSN:0012-3706
出版商:OVID
年代:1998
数据来源: OVID
|
15. |
Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis |
|
Diseases of the Colon & Rectum,
Volume 41,
Issue 1,
1998,
Page 93-97
P. Gionchetti,
F. Rizzello,
A. Venturi,
M. Ferretti,
C. Brignola,
M. Miglioli,
M. Campieri,
Preview
|
PDF (580KB)
|
|
摘要:
PURPOSE:The aim of our study was to compare the efficacy and safety of oral mesalazine with mesalazine suppositories in patients with active ulcerative proctitis.PATIENTS AND METHODS:A four‐week, randomized, single‐blind trial was performed in 58 patients with active, histologically confirmed ulcerative proctitis (≤15 cm) to evaluate the efficacy and safety of oral 800‐mg mesalazine tablets taken three times per day (n=29) compared with 400 mg of mesalazine suppositories administered three times per day (n=29). Patients were evaluated at study entry and after two and four weeks. Efficacy evaluations included a disease activity index, which represents a score with four variables: stools frequency, rectal bleeding, mucosal appearance, and physician's assessment of disease severity. Histologic activity was also assessed at study entry and after two and four weeks in accordance with the criteria by Truelove and Richard. Safety assessment included clinical laboratory parameters and adverse event reports.RESULTS:There were no significant differences with regard to baseline comparisons of demographics and severity between the two treatment groups. Improvement in mean disease activity index score was significantly greater with suppositories compared with oral mesalazine, both at two‐week and four‐week visits (mean disease activity index scores at baseline, two, and four weeks: suppositories = 7.7, 2.59, and 1.48; tablets = 7.42, 5.72, and 3.48, respectively (P<0.001)). The rate of histologic remission was significantly greater with suppositories compared with tablets both at two and four weeks (P<0.01). There were no significant differences in adverse events or clinical laboratory results between treatment groups.CONCLUSIONS:Results of this study indicate that treatment with mesalazine suppositories produces earlier and significantly better results than oral mesalazine in the treatment of active ulcerative proctitis.
ISSN:0012-3706
出版商:OVID
年代:1998
数据来源: OVID
|
16. |
Treatment of therapy‐resistant perineal metastatic Crohn's disease after proctectomy using anti‐tumor necrosis factor chimeric monoclonal antibody, cA2Report of two cases |
|
Diseases of the Colon & Rectum,
Volume 41,
Issue 1,
1998,
Page 98-102
Hendrik van Dullemen,
Ella de Jong,
Frederik Slors,
Guido N. Tytgat,
Sander J. van Deventer,
Preview
|
PDF (1830KB)
|
|
摘要:
PURPOSE:Two young females with well‐documented Crohn's disease and nonhealing perineal wounds following proctectomy compatible with “metastatic Crohn's disease” are described. We hypothesized that metastatic Crohn's disease would be a tumor necrosis factor‐dependent inflammatory reaction and have treated these two patients with the anti‐tumor necrosis factor chimeric monoclonal antibody, cA2.MAIN FINDINGS:Administration of cA2 was followed by a rapid reduction of subjective and objective parameters of inflammation and caused a substantial reduction of the wound size.CONCLUSION:These preliminary data are consistent with a tumor necrosis factor‐dependent inflammatory cause of Crohn's disease and its extraintestinal manifestations and provide support for targeting tumor necrosis factor in this condition.
ISSN:0012-3706
出版商:OVID
年代:1998
数据来源: OVID
|
17. |
Anal duct/gland cystReport of a case and review of the literature |
|
Diseases of the Colon & Rectum,
Volume 41,
Issue 1,
1998,
Page 103-110
Mahmoud Kulaylat,
Ralph Doerr,
Mike Neuwirth,
Sateesh Satchidanand,
Preview
|
PDF (1204KB)
|
|
摘要:
PURPOSE:The purpose of this communication is to report a case of anal duct/gland cyst and review cases of perianal and presacrococcygeal mucus‐secreting cysts reported in the literature with emphasis on their histopathologic features.METHOD:Our patient presented with coccydynia. An extraluminal retrorectal tumor was felt on rectal examination. A computerized tomographic scan demonstrated a presacrococcygeal mass closely related to the anorectal junction. The tumor and the coccyx were excised using a posterior approach. Cases of perianal and presacroccygeal mucus‐secreting cysts reported in the literature were reviewed.RESULTS:In our case, the tumor proved to be an anal duct/gland cyst. Some of the reported cases of presacrococcygeal glandular cysts had histopathologic features suggestive of anal duct/gland origin.CONCLUSION:Diagnosis of anal duct/gland cyst is based on routine histologic features, histochemical characteristics of mucus, and/or the presence of a communication with an anal duct or crypt. Based on these criteria, some of the reported cases of mucus‐secreting cysts occurring around the anorectum may prove to be anal duct/gland in origin.
ISSN:0012-3706
出版商:OVID
年代:1998
数据来源: OVID
|
18. |
Squamous‐cell carcinoma developing within anal lichen planusReport of a case |
|
Diseases of the Colon & Rectum,
Volume 41,
Issue 1,
1998,
Page 111-114
Salvatore Fundarò,
Andrea Spallanzani,
Elio Ricchi,
Alfonso Carriero,
Stefano Perrone,
Giulia Giusti,
Alberto Giannetti,
GianCarlo De Bernardinis,
Preview
|
PDF (1140KB)
|
|
摘要:
AIM:We present a case of squamous‐cell carcinoma developing within perianal lichen planus. This is a chronic or recurrent cutaneous and/or mucosal dermatosis affecting less than 1 percent of the population. Neoplastic degeneration of cutaneous lichen planus is rare; only one case of squamous‐cell carcinoma developing within perianal lichen planus has been described up until now in the international literature.CASE REPORT:Our case involved a 68‐year‐old woman with chronic, long‐term lichen planus spreading all over the vulva and perianal region and the mucosa of the anal canal, where squamous‐cell carcinoma developed within the perianal lichen planus. Treatment consisted of wide, circular excision of the perianal skin and mucosectomy of the anal canal up to as far as 1 cm above the dentate line. Reconstruction was performed by means of two V‐Y bilateral subcutaneous flaps.CONCLUSION:Wide excision was performed not only to remove the squamous‐cell carcinoma but also the lichen planus to prevent recurrence of metachronous or synchronous squamous‐cell carcinoma. Follow‐up at one year after surgery showed no local recurrence of either lichen planus or squamous‐cell carcinoma, which suggests that surgical removal should be the therapy of choice for long‐term, chronic perianal lichen planus that has proved to be resistant to medical therapy.
ISSN:0012-3706
出版商:OVID
年代:1998
数据来源: OVID
|
19. |
Gluteus maximus flap for persistent fecal fistula following rectal resectionviathe posterior approach |
|
Diseases of the Colon & Rectum,
Volume 41,
Issue 1,
1998,
Page 115-117
Tunç Yalti,
Osman Krand,
Mesut Titiz,
Preview
|
PDF (253KB)
|
|
摘要:
&NA;An alternative technique for the treatment of persistent anastomotic leak following resection of the rectumviacombined celiotomy and posterior approach is described. Lower aspect of the gluteus muscle is advanced and sutured to cover the anastomotic gap.
ISSN:0012-3706
出版商:OVID
年代:1998
数据来源: OVID
|
20. |
Mucocele of the appendix and colorectal neoplasms |
|
Diseases of the Colon & Rectum,
Volume 41,
Issue 1,
1998,
Page 118-119
Mahmoud Kulaylat,
Ralph Doerr,
Sateesh Satchidanand,
Preview
|
PDF (420KB)
|
|
ISSN:0012-3706
出版商:OVID
年代:1998
数据来源: OVID
|
|